These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 18979510)

  • 1. Tolerance and reactivity of NK cells: two sides of the same coin?
    Held W
    Eur J Immunol; 2008 Nov; 38(11):2930-3. PubMed ID: 18979510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The dynamics of natural killer cell tolerance.
    Johansson MH; Höglund P
    Semin Cancer Biol; 2006 Oct; 16(5):393-403. PubMed ID: 16935000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How do natural killer cells find self to achieve tolerance?
    Yokoyama WM; Kim S
    Immunity; 2006 Mar; 24(3):249-57. PubMed ID: 16546094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation and self-tolerance of natural killer cells.
    Gasser S; Raulet DH
    Immunol Rev; 2006 Dec; 214():130-42. PubMed ID: 17100881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Licensing of natural killer cells by self-major histocompatibility complex class I.
    Yokoyama WM; Kim S
    Immunol Rev; 2006 Dec; 214():143-54. PubMed ID: 17100882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new self: MHC-class-I-independent natural-killer-cell self-tolerance.
    Kumar V; McNerney ME
    Nat Rev Immunol; 2005 May; 5(5):363-74. PubMed ID: 15841099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NK cell tolerance and the maternal-fetal interface.
    Riley JK; Yokoyama WM
    Am J Reprod Immunol; 2008 May; 59(5):371-87. PubMed ID: 18405308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-tolerance of natural killer cells.
    Raulet DH; Vance RE
    Nat Rev Immunol; 2006 Jul; 6(7):520-31. PubMed ID: 16799471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond licensing and disarming: a quantitative view on NK-cell education.
    Brodin P; Höglund P
    Eur J Immunol; 2008 Nov; 38(11):2934-7. PubMed ID: 18979511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural killer cell tolerance licensing and other mechanisms.
    Jonsson AH; Yokoyama WM
    Adv Immunol; 2009; 101():27-79. PubMed ID: 19231592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frontiers in nephrology: the varied faces of natural killer cells in transplantation--contributions to both allograft immunity and tolerance.
    Beilke JN; Gill RG
    J Am Soc Nephrol; 2007 Aug; 18(8):2262-7. PubMed ID: 17634430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mistaken notions about natural killer cells.
    Yokoyama WM
    Nat Immunol; 2008 May; 9(5):481-5. PubMed ID: 18425104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NK cell receptors and their MHC class I ligands in host response to cytomegalovirus: insights from the mouse genome.
    Pyzik M; Kielczewska A; Vidal SM
    Semin Immunol; 2008 Dec; 20(6):331-42. PubMed ID: 18948016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural killer cell education and tolerance.
    Orr MT; Lanier LL
    Cell; 2010 Sep; 142(6):847-56. PubMed ID: 20850008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Killer Ig-like receptor ligand mismatch directs NK cell expansion in vitro.
    Rose MJ; Brooks AG; Stewart LA; Nguyen TH; Schwarer AP
    J Immunol; 2009 Oct; 183(7):4502-8. PubMed ID: 19748981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural immunology and crystallography help immunologists see the immune system in action: how T and NK cells touch their ligands.
    Chen Y; Shi Y; Cheng H; An YQ; Gao GF
    IUBMB Life; 2009 Jun; 61(6):579-90. PubMed ID: 19472182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural killer cell recognition of missing self.
    Kärre K
    Nat Immunol; 2008 May; 9(5):477-80. PubMed ID: 18425103
    [No Abstract]   [Full Text] [Related]  

  • 18. Bovine natural killer cells.
    Boysen P; Storset AK
    Vet Immunol Immunopathol; 2009 Aug; 130(3-4):163-77. PubMed ID: 19339058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet-derived transforming growth factor-beta down-regulates NKG2D thereby inhibiting natural killer cell antitumor reactivity.
    Kopp HG; Placke T; Salih HR
    Cancer Res; 2009 Oct; 69(19):7775-83. PubMed ID: 19738039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-E/human beta2-microglobulin transgenic pigs: protection against xenogeneic human anti-pig natural killer cell cytotoxicity.
    Weiss EH; Lilienfeld BG; Müller S; Müller E; Herbach N; Kessler B; Wanke R; Schwinzer R; Seebach JD; Wolf E; Brem G
    Transplantation; 2009 Jan; 87(1):35-43. PubMed ID: 19136889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.